BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/4/2015 11:55:00 AM | Browse: 1021 | Download: 1275
Publication Name World Journal of Hematology
Manuscript ID 14769
Country/Territory Australia
Received
2014-10-23 09:03
Peer-Review Started
2014-10-24 17:16
To Make the First Decision
2014-10-28 14:17
Return for Revision
2014-11-03 14:47
Revised
2014-11-11 14:04
Second Decision
2014-12-11 08:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-12-17 16:54
Articles in Press
2014-12-17 16:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-01-28 16:21
Publish the Manuscript Online
2015-02-04 11:55
ISSN 2218-6204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Hematology
Manuscript Type Minireviews
Article Title Role of novel oral anticoagulants in the management and prevention of venous thromboembolism
Manuscript Source Invited Manuscript
All Author List Helen E Jo and David J Barnes
Funding Agency and Grant Number
Corresponding Author Dr. Helen E Jo, Department of Respiratory Medicine, Royal Prince Alfred Hospital, Missenden Rd, Camperdown NSW 2050, Sydney, Australia. helenjo3008@gmail.com
Key Words Venous thromboembolism; Pulmonary embolism; Novel oral anticoagulants; Factor Xa inhibitors; Direct thrombin inhibitors
Core Tip Novel oral anticoagulants (NOACs) are emerging as viable alternatives to VKA in the treatment of venous thromboembolism. Trials have shown that they are as efficacious as current standard treatment with LMWH followed by VKA, and have potentially less bleeding associated with them. The regimes are simple and no monitoring is required and therefore it has the potential to reduce the burden of anticoagulation. Caution is required however, as testing of anticoagulant effect is limited and patient selection is important as many of the NOACs are metabolized in the liver and cleared by the kidney.
Publish Date 2015-02-04 11:55
Citation Jo HE, Barnes DJ. Role of novel oral anticoagulants in the management and prevention of venous thromboembolism. World J Hematol 2015; 4(1): 1-9
URL http://www.wjgnet.com/2218-6204/full/v4/i1/1.htm
DOI http://dx.doi.org/10.5315/wjh.v4.i1.1
Full Article (PDF) WJH-4-1.pdf
Full Article (Word) WJH-4-1.doc
Manuscript File 14769-Review.docx
Answering Reviewers 14769-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form 14769-Conflict-of-interest statement.pdf
Copyright License Agreement 14769-Copyright assignment.pdf
Peer-review Report 14769-Peer review(s).pdf
Scientific Misconduct Check 14769-CrossCheck.jpg
Scientific Editor Work List 14769-Scientific editor work list.pdf